Loading the SOTA2 catalog…
Ataraxis AI
Ataraxis AI is a precision oncology company that develops AI-based prognostic and predictive tests for oncology. Its flagship platform, Ataraxis Breast, uses AI to predict recurrence risk, chemotherapy benefit, and neoadjuvant treatment response in all breast cancer subtypes.
- Founded
- 2022
- Headquarters
- New York, USA
- Company size
- Not disclosed
- Products tracked
- 2
Products by Ataraxis AI
Pricing for Ataraxis AI
Contact sales
Contact Ataraxis AI for current plans, volume pricing, and enterprise terms.
Trust profile
Security and compliance
HIPAA
